Amy Hutchins
Papers
1
Total Citations
24
H-Index
1
About
Amy Hutchins is a pioneer in the development of high-throughput screening technologies for endocrine disruptors, with a particular focus on estrogen receptor ligands. Her landmark 1999 paper, "An Ultrahigh-Throughput Screening Assay for Estrogen Receptor Ligands," introduced a groundbreaking assay that dramatically accelerated the identification of compounds interacting with estrogen receptors. This work, cited 24 times, laid the foundation for rapid, cost-effective environmental and pharmaceutical screening, enabling researchers to assess thousands of potential ligands in a fraction of the time previously required. Hutchins’ contributions have been instrumental in advancing toxicology and drug discovery, providing tools to evaluate endocrine-disrupting chemicals and design safer therapeutics. Her assay remains a reference standard in the field, influencing subsequent studies on receptor-ligand interactions and regulatory toxicology. Through this innovative approach, Hutchins has empowered scientists to better understand the molecular mechanisms of estrogen signaling and its implications for human health.
Research Focus
Key Achievements
Top Papers
- 1An Ultrahigh-Throughput Screening Assay for Estrogen Receptor Ligands24 citations · 1999